Barclays analyst Julian Mitchell reiterated an Equal-Weight rating on the shares of Lennox International Inc (NYSE:LII) and raised the price target from…
Last Thursday, Replimune Group Inc (NASDAQ: REPL) announced an initial data snapshot from the first 75 patients from the anti-PD1 failed cutaneous melanoma cohort of the IGNYTE clinical.